Progress on the biochip in the next 12-18 months sounds...

Progress on the biochip in the next 12-18 months sounds promising. If they get some validation around analyte detection validation, this should be a catalyst for a re-rate IMO. In the mean time it's hard in the current environment for small caps to get a lot of attention before commercialization. In the mining sector it's a bit different because the methodology (find an area, drill, assess, quantify and then finally mine) is probably more clear than in a completely new tech space that's pretty hard to get your head around (at least for me!!). In mining you get a lot of excitement in the early phases prior to commercialization and then it can temper. I hope this works out in early investors way for Archer. When the commercialization might be realized there should be 'quantum' increases in share value all going well. GLTA